Huntington's Disease
- PMID: 21441583
- PMCID: PMC3098678
- DOI: 10.1101/cshperspect.a007476
Huntington's Disease
Abstract
Huntington's disease (HD) is the most common inherited neurodegenerative disease and is characterized by uncontrolled excessive motor movements and cognitive and emotional deficits. The mutation responsible for HD leads to an abnormally long polyglutamine (polyQ) expansion in the huntingtin (Htt) protein, which confers one or more toxic functions to mutant Htt leading to neurodegeneration. The polyQ expansion makes Htt prone to aggregate and accumulate, and manipulations that mitigate protein misfolding or facilitate the clearance of misfolded proteins tend to slow disease progression in HD models. This article will focus on HD and the evidence that it is a conformational disease.
Figures
References
-
- Al-Ramahi I, Lam YC, Chen H-K, de Gouyon B, Zhang M, Pérez AM, Branco J, de Haro M, Patterson C, Zoghbi HY, et al. 2006. CHIP protects from the neurotoxicity of expanded and wild-type ataxin-1 and promotes their ubiquitination and degradation. J Biol Chem 281: 26714–26724 - PubMed
-
- Ardley HC, Hung C-C, Robinson PA 2005. The aggravating role of the ubiquitin–proteasome system in neurodegeneration. FEBS Lett 579: 571–576 - PubMed
-
- Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S 2004. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431: 805–810 - PubMed
-
- Augood SJ, Faull RLM, Love DR, Emson PC 1996. Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: A detailed cellular in situ hybridization study. Neuroscience 72: 1023–1036 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical